A randomised control trial to identify the effects of cinacalcet on bone and cardiovascular health in end-stage renal disease - cinacalcet study
Phase 1
- Conditions
- Secondary hyperparathyroidism in renal failure
- Registration Number
- EUCTR2005-003871-19-GB
- Lead Sponsor
- Salford Royal Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
on renal replacement therapy
Corrected calcium >2.2 mmol/l
Parathyroidhormone > 300pg/ml
Age 18-75 yrs
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Contraindication to MR or CT scan
Atrial fibrillation
contraindication to cincalcet
moderate to severe liver disease (ALT x3 normal)
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method